<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03856502</url>
  </required_header>
  <id_info>
    <org_study_id>662809198348</org_study_id>
    <nct_id>NCT03856502</nct_id>
  </id_info>
  <brief_title>Influence of Intrathecal Dexamethasone Administration for Proximal Femoral Fractures</brief_title>
  <official_title>Impact of Intrathecal Dexamethasone Administration for Elderly Patients With Proximal Femoral Fracture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>General Hospital Sveti Duh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>General Hospital Sveti Duh</source>
  <brief_summary>
    <textblock>
      Spinal anesthesia blocks acute pain in older patients with femur fracture. Delirium is a
      common complication seen after femur fracture, affecting approximately 10-16% of patients. It
      is associated with increased mortality at 1st year, delayed rehabilitation efforts, prolonged
      length of hospital stay, poorer functional outcomes, and increased risk of nursing home
      placement.

      Intrathecal dexamethasone administration improves quality of anesthesia in patients with
      femur fracture compared to conventional spinal anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this research was to establish the influence of intrathecal dexamethasone
      administration in spinal anaesthesia with levobupivacaine on postoperative pain and changes
      of consciousness, values of cortisol levels and quality of treatment for patients with
      femoral fractures compared to spinal anaesthesia with only local anaesthetic.

      The study was planned as a prospective, observational, randomised clinical trial. A total of
      60 patients ASA2 and ASA3 status, scheduled for surgical procedures were sorted into two
      groups and underwent surgery in spinal anesthesia with levobupivacaine with or without
      dexamethsone.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 11, 2012</start_date>
  <completion_date type="Actual">July 4, 2017</completion_date>
  <primary_completion_date type="Actual">May 26, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative cognitive change</measure>
    <time_frame>Confusion Assessment Method scoring was assessed in 4 measure points: 1. one hour after surgery, 2. on the 3rd postoperative day at 9 am, 3. on the 5th postoperative day at 9 am, 4. on the 10th postoperative day at 9 am</time_frame>
    <description>Assessed using a simplified Confusion Assessment Method scoring scale, a clinical instrument for delirium assessment used by non-psychiatric medical staff after surgery for excluding delirium. Delirium is defined in terms of 4 possible diagnostic criteria (1. acute onset or fluctuating course; 2- inattention; 3- disorganised thinking; 4- altered level of consciousness (may be defined as alert, lethargic, stupor or coma cognitive state)) and is defined as present when 1 plus 2 and either 3 or 4 diagnostic criteria are positive.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cortisol concentrations changes</measure>
    <time_frame>Measured in 5 measure points: 1. one hour before surgery, 2. one hour after surgery, 3. on the 3rd postoperative day at 6 am, 4. on the 5th postoperative day at 6 am, 5. on the 10th postoperative day at 6 am</time_frame>
    <description>Determined from patient's blood plasma assessed by Roche Elecsys Immunoassay System and defined from the laboratory reference points (185-624)nmol/L equal for each measure point; for single measuring 0,5 ml of patient's blood was taken</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>perioperative pain intensity: Visual Analogue Scale score</measure>
    <time_frame>Visual Analogue Scale scoring (scores: 0-10) was assessed in 5 measure points every 3 hours when patient was awake: 1. 1 h before surgery, 2. 1 h after surgery, 3. on the 3rd postoperative day, 4. on the 5th postoperative day, 5. 10th postoperative day</time_frame>
    <description>Assessed using Visual Analogue Scale score and establishing postoperative analgesic requirements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>glucose concentrations changes</measure>
    <time_frame>Measured in 5 measure points (units: mmol/L): 1. one hour before surgery, 2. one hour after surgery, 3. on the 3rd postoperative day at 6 am, 4. on the 5th postoperative day at 6 am, 5. on the 10th postoperative day at 6 am</time_frame>
    <description>Determined form patient's blood plasma assessed by Beckman Coulter AU400 and AU680 orbOlympus Glucose Analyzer 2 devices defined from the laboratory reference points (4,4-6,4)mmol/L equal for each measure point; for single measuring 0,2 ml of patient's blood was taken</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood loss</measure>
    <time_frame>During the surgical repairment and up to the removal of drainage systems (2nd postoperative day)</time_frame>
    <description>Determinated by intraoperative blood loss in mililitres, amount of blood in drainage systems in mililitres, transfusion of homologous blood in mililitres</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with pulmonary embolism</measure>
    <time_frame>During surgical reconstruction and during postoperative follow-up of up to ten postoperative days</time_frame>
    <description>Established by noted pulmonary embolism in the operating room or at the traumatology ward by the ward staff</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with heart failure</measure>
    <time_frame>During surgical reconstruction and during postoperative follow-up of up to ten postoperative days</time_frame>
    <description>Established by noted heart failure in the operating room or at the traumatology ward by the ward staff</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Platelets changes</measure>
    <time_frame>Assessed in 5 measure points: 1.one hour before surgery, 2. one hour after surgery, 3. on the 3rd postoperative day at 6 am, 4. on the 5th postoperative day at 6 am, 5. on the 10th postoperative day at 6 am</time_frame>
    <description>Determined from laboratory values of platelets data in reference points (158-424)10^9/L equal for each measure point</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haemoglobin changes</measure>
    <time_frame>Assessed in 5 measure points: 1.one hour before surgery, 2. one hour after surgery, 3. on the 3rd postoperative day at 6 am, 4. on the 5th postoperative day at 6 am, 5. on the 10th postoperative day at 6 am</time_frame>
    <description>Determined from laboratory values of haemoglobin data measured reference points (119-157)g/L equal for each measure point</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haematocrit changes</measure>
    <time_frame>Assessed in 5 measure points: 1.one hour before surgery, 2. one hour after surgery, 3. on the 3rd postoperative day at 6 am, 4. on the 5th postoperative day at 6 am, 5. on the 10th postoperative day at 6 am</time_frame>
    <description>Determined from laboratory values of haematocrit data in reference points (0,356-0,470)L/L equal for each measure point</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalisation</measure>
    <time_frame>In the time period of up to 30 days</time_frame>
    <description>Calculated by number of days preoperatively from the day of admission to the day of surgical treatment and postoperatively from the day of surgical treatment to the day of hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants who underwent surgical procedure during first 48 hours from admission</measure>
    <time_frame>Calculated in hours after the patient's admission to the hospital's Emergency Department to the point of surgical reconstruction in the time period up to 48 hours</time_frame>
    <description>It was defined if surgical procedure was performed in first 48 hours from admission to the hospital's Emergency Department or later reflecting morbidity and/or mortality</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Femoral Fracture</condition>
  <condition>Cognition Disorders</condition>
  <condition>Cortisol; Hypersecretion</condition>
  <arm_group>
    <arm_group_label>group that received dexamethasone (DLSA)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The study group of 30 patients ASA status 2 or 3 received 8 mg of dexamethasone with 12,5 mg of 0,5% of levobupivacaine intrathecally for surgical reconstruction of proximal femoral fracture. Spinal anaesthesia was performed in sitting position using middle approach in intervertebral space L2-L3 or L3-L4 with spinal needles 22-27 GA.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group without dexamethasone (LSA)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group of 30 patients ASA status 2 or 3 received 12,5 mg of 0,5% of levobupivacaine intrathecally for surgical reconstruction of proximal femoral fracture. Spinal anaesthesia was performed in sitting position using middle approach in intervertebral space L2-L3 or L3-L4 with spinal needles 22-27 GA.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>8 mg of dexamethasone</intervention_name>
    <description>Effect of intrathecally administered dexamethasone in spinal anaesthesia for surgical correction of the hip fracture.</description>
    <arm_group_label>group that received dexamethasone (DLSA)</arm_group_label>
    <other_name>Dexamethasone KRKA, Chirocaine Abbott</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>12,5 mg of 0,5 % of levobupivacaine</intervention_name>
    <description>Local anaesthetic standardly used in spinal anaesthesia for surgical correction of the hip fracture by the particular hospital's protocol.</description>
    <arm_group_label>group that received dexamethasone (DLSA)</arm_group_label>
    <arm_group_label>group without dexamethasone (LSA)</arm_group_label>
    <other_name>Chirocaine Abbott</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  cooperative ASA 2 and ASA 3 status patients with proximal femoral fractures of one leg

          -  agreed to be enrolled in the study (Informed Consent signed)

        Exclusion Criteria:

          -  patients refused to be enrolled in the study

          -  patients with pre-existing cognitive disturbances before surgery

          -  conditions or diseases with corticosteroid therapy, long term corticosteroid, diabetes
             mellitus, neurological conditions or tumors, neuroendocrine disorders or tumors

          -  breaking the study protocols

          -  patients who no longer wanted to be enrolled in the study

          -  unexpected events when the study already started
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Livija Šakić, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Sveti Duh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital &quot;Sveti Duh&quot;</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <reference>
    <citation>Neuman MD, Silber JH, Elkassabany NM, Ludwig JM, Fleisher LA. Comparative effectiveness of regional versus general anesthesia for hip fracture surgery in adults. Anesthesiology. 2012 Jul;117(1):72-92. doi: 10.1097/ALN.0b013e3182545e7c.</citation>
    <PMID>22713634</PMID>
  </reference>
  <reference>
    <citation>Association of Anaesthetists of Great Britain and Ireland, Griffiths R, Alper J, Beckingsale A, Goldhill D, Heyburn G, Holloway J, Leaper E, Parker M, Ridgway S, White S, Wiese M, Wilson I. Management of proximal femoral fractures 2011: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia. 2012 Jan;67(1):85-98. doi: 10.1111/j.1365-2044.2011.06957.x.</citation>
    <PMID>22150501</PMID>
  </reference>
  <reference>
    <citation>Borgeat A, Ekatodramis G. Orthopaedic surgery in the elderly. Best Pract Res Clin Anaesthesiol. 2003 Jun;17(2):235-44. Review.</citation>
    <PMID>12817917</PMID>
  </reference>
  <reference>
    <citation>Baumann H, Gauldie J. The acute phase response. Immunol Today. 1994 Feb;15(2):74-80. Review.</citation>
    <PMID>7512342</PMID>
  </reference>
  <reference>
    <citation>Buckingham JC. Stress and the hypothalamo-pituitary-immune axis. Int J Tissue React. 1998;20(1):23-34. Review.</citation>
    <PMID>9561443</PMID>
  </reference>
  <reference>
    <citation>Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 1984 Winter;5(1):25-44. Review.</citation>
    <PMID>6368214</PMID>
  </reference>
  <reference>
    <citation>Desborough JP. The stress response to trauma and surgery. Br J Anaesth. 2000 Jul;85(1):109-17. Review.</citation>
    <PMID>10927999</PMID>
  </reference>
  <reference>
    <citation>Høgevold HE, Lyberg T, Kähler H, Haug E, Reikerås O. Changes in plasma IL-1beta, TNF-alpha and IL-6 after total hip replacement surgery in general or regional anaesthesia. Cytokine. 2000 Jul;12(7):1156-9.</citation>
    <PMID>10880268</PMID>
  </reference>
  <reference>
    <citation>Kehlet H. Manipulation of the metabolic response in clinical practice. World J Surg. 2000 Jun;24(6):690-5. Review.</citation>
    <PMID>10773121</PMID>
  </reference>
  <reference>
    <citation>Bani-Hashem N, Hassan-Nasab B, Pour EA, Maleh PA, Nabavi A, Jabbari A. Addition of intrathecal Dexamethasone to Bupivacaine for spinal anesthesia in orthopedic surgery. Saudi J Anaesth. 2011 Oct;5(4):382-6. doi: 10.4103/1658-354X.87267.</citation>
    <PMID>22144925</PMID>
  </reference>
  <reference>
    <citation>Kroin JS, Schaefer RB, Penn RD. Chronic intrathecal administration of dexamethasone sodium phosphate: pharmacokinetics and neurotoxicity in an animal model. Neurosurgery. 2000 Jan;46(1):178-82; discussion 182-3.</citation>
    <PMID>10626948</PMID>
  </reference>
  <reference>
    <citation>Yao XL, Cowan MJ, Gladwin MT, Lawrence MM, Angus CW, Shelhamer JH. Dexamethasone alters arachidonate release from human epithelial cells by induction of p11 protein synthesis and inhibition of phospholipase A2 activity. J Biol Chem. 1999 Jun 11;274(24):17202-8.</citation>
    <PMID>10358078</PMID>
  </reference>
  <reference>
    <citation>Dong Y, Zhang X, Tang F, Tian X, Zhao Y, Zhang F. Intrathecal injection with methotrexate plus dexamethasone in the treatment of central nervous system involvement in systemic lupus erythematosus. Chin Med J (Engl). 2001 Jul;114(7):764-6.</citation>
    <PMID>11780346</PMID>
  </reference>
  <reference>
    <citation>Williams BA, Hough KA, Tsui BY, Ibinson JW, Gold MS, Gebhart GF. Neurotoxicity of adjuvants used in perineural anesthesia and analgesia in comparison with ropivacaine. Reg Anesth Pain Med. 2011 May-Jun;36(3):225-30. doi: 10.1097/AAP.0b013e3182176f70.</citation>
    <PMID>21519308</PMID>
  </reference>
  <reference>
    <citation>Benzon HT, Chew TL, McCarthy RJ, Benzon HA, Walega DR. Comparison of the particle sizes of different steroids and the effect of dilution: a review of the relative neurotoxicities of the steroids. Anesthesiology. 2007 Feb;106(2):331-8.</citation>
    <PMID>17264728</PMID>
  </reference>
  <reference>
    <citation>Kopacz DJ, Lacouture PG, Wu D, Nandy P, Swanton R, Landau C. The dose response and effects of dexamethasone on bupivacaine microcapsules for intercostal blockade (T9 to T11) in healthy volunteers. Anesth Analg. 2003 Feb;96(2):576-82, table of contents.</citation>
    <PMID>12538215</PMID>
  </reference>
  <reference>
    <citation>Macro M, Reznik Y, Leymarie P, Loyau G, Mahoudeau J. The effect of intrathecal dexamethasone injection on plasma cortisol level. Br J Rheumatol. 1991 Jun;30(3):238.</citation>
    <PMID>2049597</PMID>
  </reference>
  <reference>
    <citation>Björkelund KB, Hommel A, Thorngren KG, Gustafson L, Larsson S, Lundberg D. Reducing delirium in elderly patients with hip fracture: a multi-factorial intervention study. Acta Anaesthesiol Scand. 2010 Jul;54(6):678-88. doi: 10.1111/j.1399-6576.2010.02232.x. Epub 2010 Mar 15.</citation>
    <PMID>20236093</PMID>
  </reference>
  <reference>
    <citation>Rasmussen LS, O'Brien JT, Silverstein JH, Johnson TW, Siersma VD, Canet J, Jolles J, Hanning CD, Kuipers HM, Abildstrom H, Papaioannou A, Raeder J, Yli-Hankala A, Sneyd JR, Munoz L, Moller JT; ISPOCD2 Investigators. Is peri-operative cortisol secretion related to post-operative cognitive dysfunction? Acta Anaesthesiol Scand. 2005 Oct;49(9):1225-31.</citation>
    <PMID>16146456</PMID>
  </reference>
  <reference>
    <citation>Mouzopoulos G, Vasiliadis G, Lasanianos N, Nikolaras G, Morakis E, Kaminaris M. Fascia iliaca block prophylaxis for hip fracture patients at risk for delirium: a randomized placebo-controlled study. J Orthop Traumatol. 2009 Sep;10(3):127-33. doi: 10.1007/s10195-009-0062-6. Epub 2009 Aug 19.</citation>
    <PMID>19690943</PMID>
  </reference>
  <reference>
    <citation>Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990 Dec 15;113(12):941-8.</citation>
    <PMID>2240918</PMID>
  </reference>
  <reference>
    <citation>Huang YF, Liang J, Shyu YL. Number of Comorbidities Negatively Influence Psychological Outcomes of the Elderly Following Hip Fracture in Taiwan. J Aging Health. 2016 Dec;28(8):1343-1361. doi: 10.1177/0898264315618922. Epub 2016 Jul 8.</citation>
    <PMID>26786859</PMID>
  </reference>
  <reference>
    <citation>Drews T, Franck M, Radtke FM, Weiss B, Krampe H, Brockhaus WR, Winterer G, Spies CD. Postoperative delirium is an independent risk factor for posttraumatic stress disorder in the elderly patient: a prospective observational study. Eur J Anaesthesiol. 2015 Mar;32(3):147-51. doi: 10.1097/EJA.0000000000000107.</citation>
    <PMID>24979586</PMID>
  </reference>
  <reference>
    <citation>Le Manach Y, Collins G, Bhandari M, Bessissow A, Boddaert J, Khiami F, Chaudhry H, De Beer J, Riou B, Landais P, Winemaker M, Boudemaghe T, Devereaux PJ. Outcomes After Hip Fracture Surgery Compared With Elective Total Hip Replacement. JAMA. 2015 Sep 15;314(11):1159-66. doi: 10.1001/jama.2015.10842.</citation>
    <PMID>26372585</PMID>
  </reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>November 2, 2018</study_first_submitted>
  <study_first_submitted_qc>February 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2019</study_first_posted>
  <last_update_submitted>February 26, 2019</last_update_submitted>
  <last_update_submitted_qc>February 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>General Hospital Sveti Duh</investigator_affiliation>
    <investigator_full_name>Livija Šakić, MD,PhD</investigator_full_name>
    <investigator_title>MD,PhD Anesthesiology, Reanimatology and Intensive Medicine</investigator_title>
  </responsible_party>
  <keyword>spinal anesthesia</keyword>
  <keyword>femoral fracture</keyword>
  <keyword>dexamethasone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Femoral Fractures</mesh_term>
    <mesh_term>Cognition Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The research has been a doctoral thesis.</ipd_description>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>https://hrcak.srce.hr/106014</doc_url>
    </study_doc>
    <study_doc>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>https://hrcak.srce.hr/143046</doc_url>
    </study_doc>
    <study_doc>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>https://www.bib.irb.hr/889771</doc_url>
    </study_doc>
    <study_doc>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>https://www.bib.irb.hr/889781</doc_url>
    </study_doc>
    <study_doc>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>https://www.bib.irb.hr/889773</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

